Showing 1 - 6 results of 6 for search 'Hegewisch-Becker, S', query time: 0.03s
Refine Results
-
1
Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients—Analysis of... by Sebastian Stintzing, Boryana Ivanova, Boryana Ivanova, Ingrid Ricard, Andreas Jung, Thomas Kirchner, Andrea Tannapfel, Hendrik Juette, Susanna Hegewisch-Becker, Dirk Arnold, Anke Reinacher-Schick
Published 2018-11-01
Article -
2
Cytokeratin-18 fragments predict treatment response and overall survival in gastric cancer in a randomized controlled trial by Michael Nagel, Julia Schulz, Annett Maderer, Katrin Goepfert, Nadine Gehrke, Thomas Thomaidis, Peter C Thuss-Patience, Salah E Al-Batran, Susanna Hegewisch-Becker, Peter Grimminger, Peter Robert Galle, Markus Möhler, Jörn Markus Schattenberg
Published 2018-03-01
Article -
3
Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of... by Luber Birgit, Deplazes Joëlle, Keller Gisela, Walch Axel, Rauser Sandra, Eichmann Martin, Langer Rupert, Höfler Heinz, Hegewisch-Becker Susanna, Folprecht Gunnar, Wöll Ewald, Decker Thomas, Endlicher Esther, Lorenzen Sylvie, Fend Falko, Peschel Christian, Lordick Florian
Published 2011-12-01
Article -
4
Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC) by Carl Christoph Schimanski, Stefan Kasper, Susanna Hegewisch-Becker, Jan Schröder, Friedrich Overkamp, Frank Kullmann, Wolf Otto Bechstein, Matthias Vöhringer, Robert Öllinger, Florian Lordick, Volker Heinemann, Michael Geißler, Armin Schulz-Abelius, Helga Bernhard, Michael R. Schön, Richard Greil, Peter Galle, Hauke Lang, Irene Schmidtmann, Markus Moehler
Published 2020-01-01
Article -
5
NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer. by Gnjatic, S, Cao, Y, Reichelt, U, Yekebas, E, Nölker, C, Marx, A, Erbersdobler, A, Nishikawa, H, Hildebrandt, Y, Bartels, K, Horn, C, Stahl, T, Gout, I, Filonenko, V, Ling, K, Cerundolo, V, Luetkens, T, Ritter, G, Friedrichs, K, Leuwer, R, Hegewisch-Becker, S, Izbicki, JR, Bokemeyer, C, Old, L, Atanackovic, D
Published 2010Journal article -
6
Translational analysis and final efficacy of the AVETUX trial – Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer by Joseph Tintelnot, Inka Ristow, Markus Sauer, Donjete Simnica, Christoph Schultheiß, Rebekka Scholz, Eray Goekkurt, Eray Goekkurt, Lisa von Wenserski, Edith Willscher, Lisa Paschold, Sylvie Lorenzen, Jorge Riera-Knorrenschild, Reinhard Depenbusch, Thomas J. Ettrich, Steffen Dörfel, Salah-Eddin Al-Batran, Meinolf Karthaus, Uwe Pelzer, Axel Hinke, Marcus Bauer, Chiara Massa, Barbara Seliger, Claudia Wickenhauser, Carsten Bokemeyer, Susanna Hegewisch-Becker, Mascha Binder, Alexander Stein, Alexander Stein
Published 2022-12-01
Article